Φορτώνει......
Mepolizumab in the treatment of eosinophilic chronic obstructive pulmonary disease
Despite maximal medical therapy, a subset of patients with chronic obstructive pulmonary disease continue to suffer acute exacerbations. It is also clear that a subset of this population has elevated blood eosinophils. In addition to clearly responding better to inhaled corticosteroids, it is also p...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Int J Chron Obstruct Pulmon Dis |
|---|---|
| Κύριοι συγγραφείς: | , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Dove
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6689550/ https://ncbi.nlm.nih.gov/pubmed/31496677 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S162781 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|